
Take2 AI is an AI-Powered job simulation platform for sales recruiting & training. We are on a mission to reinvent how companies recruit and train talent for high volume sales roles. Take2 AI helps companies generate tailor-made simulations of real-world sales scenarios that vet job applicants for skills, behavioral attributes and culture fit. By leveraging generative AI, Take2 recreates company and role specific sales scenarios that not only provide high-signal performance data to employers, but also immerse job applicants in the role, leading to fewer mis-hires and reduced short-term attrition. We are a team of Stanford GSB Alums, backed by SemperVirens & Reach Capital. Our advisory board consists of HR Leaders from Visa, HP, Disney and Google.

Take2 AI is an AI-Powered job simulation platform for sales recruiting & training. We are on a mission to reinvent how companies recruit and train talent for high volume sales roles. Take2 AI helps companies generate tailor-made simulations of real-world sales scenarios that vet job applicants for skills, behavioral attributes and culture fit. By leveraging generative AI, Take2 recreates company and role specific sales scenarios that not only provide high-signal performance data to employers, but also immerse job applicants in the role, leading to fewer mis-hires and reduced short-term attrition. We are a team of Stanford GSB Alums, backed by SemperVirens & Reach Capital. Our advisory board consists of HR Leaders from Visa, HP, Disney and Google.
What they do: AI-powered job-simulation platform for high-volume sales and healthcare recruiting
Stage / funding: Seed — $3.0M seed round announced April 2024
Founders: Kaushik Narasimhan and Yaniv Shimoni
Team size: About 15 employees
High-volume recruiting and candidate screening for frontline sales and healthcare roles.
2021
Software Development
$3.0M
Syndicate included Techstars, Sequoia Scout program, Honeystone Ventures, J4.Ventures, Moai Capital, Gurtin Ventures, Manousos Investments and others
“Backed by education- and early-stage focused investors (Reach Capital, SemperVirens) and a syndicate including seed investors and scout programs”
| Company |
|---|